A triple-blind, placebo-controlled, randomized clinical trial to evaluate the effect of curcumin-containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID-19 patients.
Phytother Res
; 35(11): 6417-6427, 2021 Nov.
Article
en En
| MEDLINE
| ID: mdl-34541720
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Curcumina
/
COVID-19
Tipo de estudio:
Clinical_trials
Límite:
Humans
Idioma:
En
Año:
2021
Tipo del documento:
Article